Industries > Pharma > Global Precision Medicine Market Forecast 2018-2028

Global Precision Medicine Market Forecast 2018-2028

Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases

PUBLISHED: 26 March 2018
PAGES: 233
PRODUCT CODE: PHA0295

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global precision medicine market is expected to grow at an estimated CAGR of 12.08% from 2018 to 2028. The diagnostic tool companies segment is dominating the global market and accounted for $15,974.4 million in 2017 due to the increasing demand for diagnostic and genetic tests.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 233-page report you will receive 116 tables and 56 figures– all unavailable elsewhere.

The 233-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Precision Medicine Market forecasts from 2018-2028

• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2028 for the market segmented by technology:
• Companion Diagnostics
• Biomarker-based Test
• Targeted Therapeutics
• Pharmacogenomics
• Molecular Diagnostics

The forecast for each market segment is further broken down by ecosystem player and therapeutic application

For each segment, the report discusses key trends, developments and participants.

• This report breaks down the precision medicine market forecast to 2028 by ecosystem players:
• Pharmaceuticals & Biotechnology Companies
• Diagnostic Companies
• Healthcare IT/Big Data Companies
• Clinical Laboratories

The forecast for each market segment is further broken down by technology, therapeutic application and geography.

For each segment, the report discusses key trends, developments and participants.

• This report also breaks down the precision medicine market forecast to 2028 by therapeutic application:
• Cancer
• Cardiovascular Diseases
• Central Nervous System
• Infectious Diseases

The forecast for each market segment is further broken down by ecosystem player, technology and geography.

For each segment, the report discusses key trends, developments and participants.

• This study provides precision medicine market forecasts to 2028 for these regional markets:
• The Americas
• Europe
• Asia-Pacific
• RoW

The forecast for each regional market is further broken down by ecosystem player and therapeutic application

For each regional market, the report discusses key trends, developments and participants.

• This report profiles selected leading companies that are the main players in the global precision medicine market:
• Abbott Laboratories
• GE Healthcare
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Pfizer
• Laboratories Corporation of America Holdings
• Danaher Corporation

Global Precision Medicine Market Forecast 2018-2028

• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.

• This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis

• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.

Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.

Buy our report today Global Precision Medicine Market Forecast 2018-2028: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 Global Precision Medicine Market Overview

1.1.1 Precision Medicine Market – Segmentation by Technology

1.1.2 Precision Medicine Market – Segmentation by Ecosystem Players

1.1.3 Precision Medicine Market – Segmentation by Therapeutic Application

1.1.4 Precision Medicine Market – Segmentation by Geography

1.2 Why You Should Read This Report

1.3 How This Report Delivers

1.4 Key Questions Answered by This Analytical Report Include

1.5 Who is This Report For?

1.6 Methodology

1.6.1 Primary Research

1.6.2 Secondary Research

1.6.3 Market Evaluation & Forecasting Methodology

1.7 Frequently Asked Questions (FAQ)

1.8 Associated Visiongain Reports

1.9 About Visiongain


2. Introduction to Precision Medicine

2.1 Evolution and Brief History of Precision Medicine

2.2 Key Benefits of Precision Medicine

2.3 Precision Medicine: Key Areas of Application

2.4 Precision Medicine: Key Elements

2.5 Precision Medicine: Different Type of Data Used by Big Data Companies

2.6 Precision Medicine: Area of Interest


3. Global Precision Medicine Market 2018-2028

3.1 Global Precision Medicine Market by Ecosystem, 2018-2028

3.2 Global Precision Medicine Market by Technology, 2018-2028

3.3 Global Precision Medicine Market by Therapeutic Application, 2018-2028

3.4 Global Precision Medicine Market by Geography, 2018-2028


4. Market Dynamics

4.1 Global Precision Medicine Market Drivers

4.1.1 Upcoming Technologies in Healthcare

4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies

4.1.3 Greater Involvement in Personal Healthcare

4.1.4 A Rise in Genetic Diseases

4.1.5 Growing Deamnd for Targeted Therapies

4.2 Global Precision Medicine Market Restraints

4.2.1 Limitations in Application due to Lack of Research and Evidences

4.2.2 Stringent Regulatory Framework and Reimbursement Policies

4.2.3 Stringent Regulations and Standards

4.2.4 Higher Cost of Diagnostic

4.2.5 Risk to Personal Data

4.2.6 Risk of failure of Software or Hardware

4.2.7 Lack of Knowledge and Awareness

4.3 Global Precision Medicine Market Opportunities

4.3.1 Increasing Awareness in Developing Economies

4.3.2 Reduction in the cost of Genome Sequencing

4.4 Regulatory Bodies

4.4.1 Food and Drug Administration (FDA)

4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA)

4.4.3 Therapeutic Goods Administration (TGA)-Australia

4.4.4 Conformité Européenne (CE)

4.5 Consortiums

4.6 Alliances/Associations


5. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Ecosystem Players

5.1 Introduction

5.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Ecosystem Players

5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2018-2028

5.2.1 Key Market Trends, Developments and Participants

5.2.1.1 Market Trends

5.2.1.2 Market Developments

5.2.1.3 Key Participants

5.3 Global Diagnostic Tools Companies Submarket Forecast 2018-2028

5.3.1 Key Market Trends, Developments and Participants

5.3.1.1 Market Trends

5.3.1.2 Market Developments

5.3.1.3 Key Participants

5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2018-2028

5.4.1 Key Market Trends, Developments And Participants

5.4.1.1 Market Trends

5.4.1.2 Market Developments

5.4.1.3 Key Participants

5.5 Global Clinical Laboratories Submarket Forecast 2018-2028

5.5.1 Key Market Trends, Developments And Participants

5.5.1.1 Regulatory bodies and compliances

5.5.1.2 Market Trends

5.5.1.3 Key Participants


6. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Technology

6.1 Introduction

6.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Technology

6.2 Global Companion Diagnostics Submarket Forecast 2018-2028

6.3 Global Biomarker-based Test Submarket Forecast 2018-2028

6.3.1 Role of Biobanking in Biomarker

6.3.2 Key Participants

6.4 Global Targeted Therapeutics Submarket Forecast 2018-2028

6.4.1 Key Participants

6.5 Global Pharmacogenomics Submarket Forecast 2018-2028

6.5.1 Key Market Trends, Developments And Participants

6.5.1.1 Market Trends

6.5.1.2 Market Developments

6.5.1.3 Key Participants

6.6 Global Molecular Diagnostics Submarket Forecast 2018-2028

6.7 Global Other Technology Submarket Forecast 2018-2028

6.8 Next-Generation Sequencing

6.9 Consumer Genomics

6.10 3D Printing

6.11 Prosthetics Market

6.12 Human Tissues Market


7. Global Precision Medicine Market Forecast 2018-2028: Segmented by Therapeutic Application

7.1 Introduction

7.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Therapeutic Application

7.2 Global Cancer Submarket Forecast 2018-2028

7.2.1 Types of cancer

7.2.2 Key Market Trends, Developments & Participants

7.2.2.1 Market Trends

7.2.2.2 Market Developments

7.2.2.3 Key Participants

7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2018-2028

7.3.1 Drugs & Tests

7.3.2 Market Trends & Market Developments

7.3.2.1 Market trend

7.3.2.2 Market Developments

7.3.2.3 Key Participants

7.4 Global Central Nervous System Market Forecast 2018-2028

7.4.1 Neurological

7.4.1.1 Neurological Drugs & Tests

7.4.2 Psychiatric Disorders

7.4.2.1 Psychiatric Disorder Drugs & Tests

7.4.3 Market tends & Market Developments

7.4.3.1 Market Trends

7.4.3.2 Key Participants

7.5 Global Infectious Diseases Submarket Forecast 2018-2028

7.5.1 Infectious Diseases Drugs & Tests

7.5.2 Market Developments & participants

7.5.2.1 Key Developments

7.5.2.2 Key Participants

7.6 Global Other Therapeutic Application Submarket Forecast 2018-2028

7.6.2 Market trends, Developments & Participants

7.6.2.1 Market Trends

7.6.2.2 Key Developments

7.6.2.3 Key Participants


8. Global Precision Medicine Market Forecast 2018-2028 – Segmented by Geography

8.1 Introduction

8.2 The Americas Precision Medicine Market Forecast 2018-2028

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.1.3 Key Market Trends, Developments and Participants

8.2.1.3.1 Regulations and Compliances

8.2.1.3.2 Market Trends

8.2.1.3.3 Market Developments

8.2.1.4 Key Participants

8.2.2 South America

8.2.2.1 Key Market Trends, Developments and Participants

8.2.2.1.1 Regulations and Compliances

8.2.2.1.2 Market Trends

8.2.2.2 Key Participants

8.3 Europe Precision Medicine Market Forecast 2018-2028

8.3.1 Key Market Trends, Developments And Participants

8.3.1.1 Regulations and Compliances

8.3.1.2 Market Developments

8.3.1.3 Key Participants

8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2018-2028

8.4.1 Key Market Trends, Developments and Participants

8.4.1.1 Market Developments

8.4.1.2 Key Participants

8.5 Rest of the World/Midde East & Africa (MEA) Precision Medicine Market Forecast 2018-2028

8.5.3 Key Market Developments And Participants

8.5.3.1 Market Developments

8.5.3.2 Key Participants


9. Market Analysis

9.1 Porter’s Five Forces Analysis

9.1.1 Bargaining Power of Supplier

9.1.2 Bargaining Power of Buyer

9.1.3 Industry Rivalry

9.1.4 Threat of New Entrants

9.1.5 Threat of Substitutes

9.2 Value Chain Analysis

9.2.1 Device Manufacturer & Drug Producers

9.2.2 Healthcare Providers

9.2.3 Healthcare IT Or Big Data Companies

9.2.4 Regulators

9.2.5 Third Party Payers

9.2.6 Patients


10. Company Profiles

10.1 Abbott Laboratories: Overview

10.1.1 Abbott Laboratories: Products & Service

10.1.2 Abbott Laboratories: Key Developments

10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy

10.2 GE Healthcare: Overview

10.2.1 GE Healthcare: Products & Service

10.2.2 GE Healthcare: Key Developments

10.2.3 GE Healthcare: Future Outlook and Growth Strategy

10.3 GlaxoSmithKline plc: Overview

10.3.1 GlaxoSmithKline plc: Products & Service

10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy

10.4 Johnson & Johnson: Overview

10.4.1 Johnson & Johnson: Products & Service

10.4.2 Johnson & Johnson: Key Developments

10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy

10.5 Pfizer Inc.: Overview

10.5.1 Pfizer Inc.: Products & Service

10.5.2 Pfizer Inc.: Key Developments

10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy

10.6 Laboratory Corporation of America Holdings Overview

10.6.1 Laboratory Corporation of America Holdings: Products & Service

10.6.2 Laboratory Corporation of America Holdings: Key Developments

10.7 Danaher Corporation: Overview

10.7.1 Danaher Corporation: Products & Service

10.7.2 Danaher Corporation: Key Developments

10.7.3 Danaher Corporation: Future Outlook and Growth Strategy


11. Competitive Landscape

11.1 Introduction

11.1.1 Partnerships, Collaborations and Joint Ventures

11.1.2 Product Launch/Development

11.1.3 Acquisitions

11.1.4 Expansion

11.1.5 Patents, Approvals and Certifications

11.1.6 Others


Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form


List of Tables

Table 2.1 Key Benefits of Precision Medicine

Table 2.2 Key Elements of Precision Medicine

Table 4.1 Key Benefits of Precision Medicine for Patients

Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry

Table 4.3 Key Consortiums in the Precision Medicine Industry

Table 4.4 Key Alliances/Associations in the Precision Medicine Industry

Table 5.1 Global Precision Medicine Market Forecast by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.2 Global Pharma & Biotech Companies Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.3 Global Pharma & Biotech Companies Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.4 Global Pharma & Biotech Companies Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.5 Key Developments In Pharma & Biotech Companies

Table 5.6 Global Diagnostic Tool Companies Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.7 Global Diagnostic Tool Companies Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.8 Global Diagnostic Tool Companies Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.9 Key Developments In Diagnostic Companies

Table 5.10 Global Healthcare ITs/Big Data Submarket by Technology: Revenue ($m), AGR (%), CAGR (%)

Table 5.11 Global Healthcare ITs/Big Data Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%)

Table 5.12 Global Healthcare ITs/Big Data Submarket by Geography: Revenue ($m), AGR (%), CAGR (%)

Table 5.13 Key Developments In Healthcare IT/Big Data Companies

Table 5.14 Clinical Laboratories: Global Precision Medicine Market Value by Sub-Market Types: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.15 Clinical Laboratories: Global Precision Medicine Market Value by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%)

Table 5.16 Clinical Laboratories: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.1 Global Precision Medicine Market by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.2 Global Companion Diagnostics Subamarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.3 Global Companion Diagnostics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.4 List Of Approved Companion Diagnostic Devices

Table 6.5 Global Biomarker-based Test Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.6 Global Biomarker-based Test Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.7 List of Biobanks

Table 6.8 Examples Of Biobanking Initiatives Across Selected OECD Countries

Table 6.9 Global Targeted Therapeutic Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.10 Global Targeted Therapeutic Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.11 Global Pharmacogenomics Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.12 Global Pharmacogenomics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.13 Market Developments

Table 6.14 Global Molecular Diagnostics Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.15 Global Molecular Diagnostics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.16 Some Examples of Human Genetic Tests That Have Been Approved by the FDA

Table 6.17 Some Examples of Microbial Tests That Have Been Approved by the FDA

Table 6.18 Global Others Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.19 Global Others Submarket Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.1 Global Precision Medicine Market by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.2 Global Cancer Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.3 Global Cancer Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.4 Global Cancer Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.5 Precision Medicine Drugs And Relevant Genes: Oncology

Table 7.6 Precision Medicine Genetic Tests With Respect To Oncology

Table 7.7 Key Developments

Table 7.8 Global Cardiovascular Diseases Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.9 Global Cardiovascular Diseases Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.10 Global Cardiovascular Diseases Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.11 Precision Medicine Drugs And Relevant Genes: Cardiovascular

Table 7.12 Precision Medicine Genetic Tests With Respect to Cardiovascular

Table 7.13 Key Developments

Table 7.14 Global CNS Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.15 Global CNS Submarket by Technology: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.16 CNS: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.17 Precision Medicine Drugs And Relevant Genes: Neurology

Table 7.18 Precision Medicine Drugs And Relevantgenes: Psychiatric Disorders

Table 7.19 Precision Medicine Genetic Tests With Respect to Psychiatric Disorders

Table 7.20 Psychiatric Disorders: Key Developments

Table 7.21 Global Infectious Disease Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%)

Table 7.22 Global Infectious Disease Submarket by Technology: Revenue ($m), AGR (%), CAGR (%)

Table 7.23 Global Infectious Disease Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.24 Precision Medicine Drugs and Relevant Genes: Infectious Diseases

Table 7.25 Key Developments

Table 7.26 Global Other Therapeutic Application by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.27 Global Other Therapeutic Application by Technology: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.28 Other Therapeutics: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.29 Precision Medicine Drugs And Relevant Genes: Other Diseases

Table 7.30 Precision Medicine Genetic Tests With Respect To Other Diseases

Table 7.31 Key Developments

Table 8.1 Global Precision Medicine Market by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.2 Americas Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.3 Americas Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.4 Market Developments

Table 8.5 Europe Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.6 Europe Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.7 Market Developments

Table 8.8 APAC Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.9 APAC Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.10 Market Developments

Table 8.11 ROW Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.12 ROW Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.13 Market Developments

Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers

Table 9.2 Key Factors Affecting the Bargaining Power of Buyer

Table 9.3 Key Factors Affecting the Industry Rivalry

Table 9.4 Key Factors Affecting the Threat of New Entrants

Table 9.5 Key Factors Affecting the Threat of Substitutes

Table 10.1 Abbott Laboratories Overview

Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income

Table 10.3 Abbott Laboratories : Key Developments

Table 10.4 GE Healthcare Overview

Table 10.5 GE Healthcare: 5-year Revenue, Profit

Table 10.6 GE Healthcare: Key Developments

Table 10.7 GlaxoSmithKline plc: Overview

Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax)

Table 10.7 Johnson & Johnson: Overview

Table 10.8 Johnson & Johnson: 5-year Revenue, Net Earnings

Table 10.9 Johnson & Johnson: Key Developments

Table 10.10 Pfizer Inc. Overview

Table 10.11 Pfizer Inc.: 5-year Revenue, Net Income, Operating Income

Table 10.12 Pfizer Inc: Key Developments

Table 10.13 Laboratory Corporation of America Holdings: Overview

Table 10.14 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income

Table 10.15 Laboratory Corporation: Key Developments

Table 10.16 Danaher Corporation: Overview

Table 10.17 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit

Table 10.18 Danaher Corporation: Key Developments

Table 11.1 Key Partnerships, Collaborations and Joint Ventures

Table 11.2 Key Product Developments

Table 11.3 Key Acquistions

Table 11.4 Key Expansion

Table 11.5 Key Patents, Approvals And Certifications

Table 11.6 Key Other Events


List of Figures

Figure 1.1 Global Precision Medicine Market – Segmentation by Technology

Figure 1.2 Global Precision Medicine Market – Segmentation by Ecosystem

Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application

Figure 1.4 Global Precision Medicine Market - Segmentation by Geography

Figure 2.1 History of Precision Medicine

Figure 2.2 Key Areas of Application of Precision Medicine

Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine

Figure 2.4 Key Areas of Interest of Precision Medicine

Figure 3.1 Global Precision Medicine Market Share by Ecosystem: Revenue ($bn), 2017-2028

Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2017-2028

Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2017-2028

Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2017-2028

Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards

Figure 4.2 FDA’s Role in Precision Medicine

Figure 5.1 Global Precision Medicine Market by Ecosystem Players

Figure 5.2 Role Of Pharmaceuticals And Biotech Companies

Figure 5.3 Challenges Faced by Pharma & Biotech Companies

Figure 5.4 Diagnostic Tests Benefits for Stakeholders

Figure 5.5 Challenges Faced by Diagnostic Companies

Figure 5.6 Benefits Of Big Data

Figure 5.7 Transformation Of Medicine

Figure 5.8 Basic Ingredients Provided by Big Data For Precision Medicine

Figure 5.9 Challenges Faced by Big Data Companies

Figure 5.10 OECD Recommendations On The Governance Of Clinical Trials

Figure 6.1 Types Of Precision Medicine Sub-Market

Figure 6.2 Benefits of Companion Diagnostics

Figure 6.3 Function Of Biomarkers

Figure 6.4 Biobanks Services

Figure 6.5 Development In PGx

Figure 6.6 Model Systems Used In PGx

Figure 6.7 Challenges Of PGx Studies

Figure 6.8 Type of Molecular Diagnostics Test

Figure 6.9 Molecular Diagnostics: Application

Figure 6.10 Molecular Diagnostics: Benefits

Figure 7.1 Global Precision Medicine Market by Therapeutics

Figure 8.1 Global Precision Medicine Market Classification by Geography

Figure 8.2 Key Drivers For Precision Medicine: North America

Figure 8.3 Objectives of the Precision Medicine Initiative

Figure 8.4 APAC: Market Challenges

Figure 9.1 Precision Medicine Market Porter’s Five Forces Analysis, 2017

Figure 9.2 Precision Medicine Market Value Chain

Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2017

Figure 10.2 Abbott Laboratories: Sales by Region (%), 2017

Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017

Figure 10.4 GE Healthcare: Sales by Geography (%), 2017

Figure 10.5 GlaxoSmithKline plc: Sales by Business

Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017

Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017

Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017

Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2017

Figure 10.10 Pfizer Inc.: Sales by Region (%), 2017

Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017

Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017

Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017

Figure 10.14 Danaher Corporation: Sales by Region (%), 2017

Figure 11.1 Precision Medicine Market Key Development Strategies

23andMe

Abbott

Abbott Molecular Inc.

Abcodia

ACS Biomarker

Actelion Pharmaceuticals Ltd.

Advanced Biological Laboratories

Affymetrix, Inc.

Agendia BV

Alberta Cancer Research Biobank

Alberta Health Services

Alberta Tumour Bank

Alios BioPharma, Inc.,

Almac Diagnostics

Almac Group

Apple

Archimedes,

Asurage, Inc.

AT&T

Athena Diagnostics

Athena Health, Inc.

Aurora

Auspex Pharmaceuticals, Inc.

Aventor

BGI Tech Solutions Co., Ltd.

Biobank Japan-Riken Institute

Biobanque de Picardie

BioFortis

BioGene

Biological Resources Centres

BioMérieux

Biotype Diagnostics

Bode Technology Group, Inc.

Canadian Biosample Repository

Cancer Research Network of the FRSQ

Capital Health/Regional Tissue Bank

CareWell Urgent Care

Caris Life Sciences

Celera Diagnostics

Cell& Co Biorepository

Central Biomaterial Bank

Cepheid

CFR Pharmaceuticals

Charité-Universitätsmedizin Berlin

Cognizant

Confederation of Cancer Biobanks

Continua Health Alliance

Cooperative Human Tissue Network

COPAN

Covance Inc.

Cubist Pharmaceuticals

Dako

Danubian Biobank Consortium Tissue Bank

Dell

Eagle Pharmaceuticals, Inc.

Emulate Inc.

Epizyme

Estonian Genome Project

Ferring Pharmaceuticals

Fisher BioServices

Foundation Medicine

GE Healthcare

Genethon DNA and Cell Bank

Genome Medicine

Genomics Inc.

GenoSpace

Gen-Probe, Inc.

German Heart Failure Network

Glooko

Google

Guangzhou RiboBio Co.

Hologic, Inc.

Human Tissue Resource Network

HUNT Biobank

IBM

Idera Pharmaceuticals Inc.

Illumina, Inc

Immuneering Corporation

Infectio Diagnostic, Inc.

Institutional Biobank of Lausanne

Intel

Intomics

Janssen Biotech Inc.

Japan Post Group

Japanese Collection of Research Bioresources

Johnson & Johnson

King’s College Inectious Diseases Biobank

Lab-Ally LLC

Laboratory Corporation of America

LG

Life technologies

Liverpool Tissue Bank

Luminex Molecular Diagnostics, Inc.

Lutron Electronics

Manitoba Breast Tumour Bank

Mayo clinic

Medpace CRO Clinical Trial Services

Medtronic plc

Modul-Bio

Molecular Health

Monogrom Bioscience

Myriad Genetic Laboratories, Inc.

Nanosphere, Inc.

NanoString

National Health Laboratories Incorporated

NHS Cod Blood Bank

Novartis de Colombia S.A.

Omnyx, LLC

OncoMed Pharmaceuticals. Inc.

Ontario Cancer Research Network

Oracle healthcare

Organovo

Panasonic Healthcare

PATH Biobank

Patient DNA collection at Institute of Human Genetics Heidelberg

Pfizer

Pfizer’s Centers for Therapeutic Innovation (CTI)

Philips Healthcare

Prasco Laboratories

Precision for Medicine

PROCURE Quebec Prostate Cancer

ProMedDx

Q2 Solutions

Qiagen

Qiagen Manchester, Ltd.

Qualcomm

Qualcomm Life, Inc.

Quartz bio

Quest Diagnostics

Randox Laboratories

Randox Toxicology

Roche

Roche Molecular Systems, Inc.

Royal Philips

Samsung

Sanofi Aventis

Siemens Clinical Lab

Signature Diagnostics AG (Signature)

Southwest France Tumour Bank

St. Jude Medical

Sterand Plc

Syapse

Sysmex

Takeda

Teva Pharmaceuticals

Therascreen

Topera, Inc.

Tumour Bank of Provence

Ventana Medical Systems, Inc.

Veropharm

Vysis

Zinfandel Pharmaceuticals


List of Organisations Mentioned in the Report

Alberta Tumour Bank

American Association for Cancer Research (AACR)

American Telemedicine Association

Association for Molecular Pathology

Beth Israel Deaconess Medical Center (BIDMC)

Biobank Japan-Riken Institute

Biobanque de Picardie

Biological Resources Centres

Canadian Biosample Repository

Canadian Institutes of Health Research (CIHR)

Cancer Research Network of the FRSQ

Capital Health/Regional Tissue Bank

Careggi University Hospital

Central Biomaterial Bank

Charité-Universitätsmedizin Berlin

Confederation of Cancer Biobanks

Conformité Européenne (CE)

Danubian Biobank Consortium Tissue Bank

Diabeter

European Association for Cancer Research (EACR)

European Diagnostics Manufacturers Association (EDMA)

European Federation of Pharmaceutical Industries and Associations (EFPIA)

EUROPEAN MEDICINES AGENCY (EMA)

European Society of Human Genetics

EUROPEAN UNION (EU) COMMISSION

Food and Drug Administration (FDA)

Foundation for Innovative New Diagnostics (FIND)

Genethon DNA and Cell Bank

German Heart Failure Network

Global Medical Technology Alliance (GMTA)

Health Science Research Resources Bank

Innovative New Diagnostics (FIND

International Human Genome Sequencing Consortium

International Medical Device Regulators Forum (IMDRF)

Japanese Collection of Research Bioresources

Japan Health Science Foundation

Japan National Cancer Center Brain Bank for Aging Research

Jeffrey Modell Foundation (JMF)

Karolinska University Hospital

King’s College Infectious Diseases Biobank

Liverpool Tissue Bank

Manitoba Breast Tumour Bank

Medicines and Healthcare Products Regulatory Agency (MHRA)

Memorial Sloan Kettering Cancer Center

Mount Sinai

National Institutes of Health (NIH)

NHS Cod Blood Bank

Norwegian University of Science and Technology

Ohio State University

Ontario Cancer Research Network

Organization of European Cancer Institute (OECI)

Patient DNA collection at Institute of Human Genetics Heidelberg

PROCURE Quebec Prostate Cancer

Queens University Belfast (QUB)

Red Cross

Roslin Wellcome Trust Tick Cell Biobank

Southwest France Tumour Bank

Stanford Health Care

The Brain Tumour Tissue Bank

The Center for Assessment Technology and Continuous Health (CATCH)

The Government Accountability Office, Patient-Centered Outcomes Research Institute

The National Center for Toxicological Research (NCTR)

The National Institute for Health Research (NIHR)

The United Kingdom Clinical Research Network (UKCRN)

The United Kingdom Clinical Research Network (UKCRN)

Therapeutic Goods Administration (TGA)

Triangle Global Health Consortium

Tumour Bank of Provence

U.K. Biobank

U.K. DNA Banking Network

U.K. Stem Cell Bank

UC Health

UMass Cancer Center Tissue and Tumor Bank

U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank

U.K. DNA Banking Network

U.K. Stem Cell Bank

UCSF

United Kingdom Clinical Research Network (UKCRN)

University Hospital of Lausanne and University of Lausanne

University of Bristol

University of Massachusetts Medical School

University of Tartu

Wireless-Life Sciences Alliance (WLSA)

Xavier University

Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2018-2028


facebookWin a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/

Would you like a free report overview of the report of your choice?

If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com

Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?

What are the dynamic growth sectors? where are the regional business opportunities?

Which technologies will prevail and who are the leading companies succeeding in these sectors and why?

If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.

If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987

  • Human Microbiome Therapeutics Market 2019-2029
  • Top 20 Urology Companies 2019
  • Global Antidepressant and Anti-Anxiety Drugs Market Forecasts 2019-2029
  • The Top 100 In-Vitro Diagnostics Companies to Watch 2019
  • Global Hypertension Drugs Market 2019-2029
  • The Next Generation Sequencing Market 2019-2029
  • Lyophilisation for Pharmaceuticals: Products and Services 2019-2029
  • Top 25 In Vitro Diagnostics (IVD) Companies 2019
  • Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market 2019-2029
  • Global Biomarkets and Technologies Market 2019-2029
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Kuwait Pharmaceutical Association
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Generic Medicines Association
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Latest Pharma news

“In 2017, the Top 5 Vaccines Manufacturers held 76% of the Global Vaccines Market” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs.

12 February 2019

READ

“Translational Regenerative Medicine market set to grow to $76bn by 2023” says new Visiongain report

Regenerative medicine has become an area of competition between many national governments, particularly in Asia-Pacific.

07 February 2019

READ

“Global Pre-Filled Syringes market set to grow to $19bn by 2024” says new Visiongain report

The market is expected to grow strongly driven by numerous trends in the overall pharmaceutical market, such as more self-administration of medicines, the development of biological drugs and biosimilars, and the increasing burden of chronic diseases such as diabetes and high cholesterol.

31 January 2019

READ

“30% of the Top Generic Drug Producers are in the ROW region” says new Visiongain report

This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017.

31 January 2019

READ

Categories

Category